SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 431,061.43 |
| Enterprise Value ($M) | 447,385.43 |
| Book Value ($M) | 69,580.00 |
| Book Value / Share | 26.43 |
| Price / Book | 6.20 |
| NCAV ($M) | -49,067.00 |
| NCAV / Share | -18.64 |
| Price / NCAV | -8.79 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.17 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.11 |
| Current Ratio | 1.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 59,889.00 |
| Assets | 179,228.00 |
| Liabilities | 108,956.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.47 | -5.16 | |
| 13G/A | Vanguard Group Inc | 8.66 | -0.15 | |
| 13G/A | BlackRock Inc. | 7.20 | -2.36 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,458,112 | 11,245,125 | 12.97 | |
| 978,519 | 8,309,177 | 11.78 | |
| 540,013 | 4,590,603 | 11.76 | |
| 684,048 | 4,484,051 | 15.26 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| ELAN – Elanco Animal Health Inc | ELAT – Elanco Animal Health Incorporated 5.00% Tangible Equity Units |
| GSK – GlaxoSmithKline plc | LCI – Lannett Company, Inc. |
| LLY – Eli Lilly And Co |
Financial data and stock pages provided by
Fintel.io
